Windlas Biotech

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE0H5O01029
NSEID: WINDLAS
BSEID: 543329

INR

960.45

63.55 (7.09%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 51.24 k

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Amrutanjan Healt

Bajaj Healthcare

Cipla

Windlas Biotech

SMS Pharma.

Sun Pharma.Inds.

Torrent Pharma

Solara Active

Mankind Pharma

Beta Drugs Ltd

Why is Windlas Biotech Ltd ?

Stock is technically in a Mildly Bearish range

The technical trend has deteriorated from Mildly Bullish on 08-Apr-25 and has generated 4.29% returns since then
The stocks Bollinger Band and KST technical factors are also Bearish

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Windlas Biotech for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Windlas Biotech

75.62%

1.45

52.54%

SENSEX

0.45%

0.04

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

17.36%

EBIT Growth (5y)

22.01%

EBIT to Interest (avg)

37.53

Debt to EBITDA (avg)

0.16

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.35

Tax Ratio

24.35%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

11.81%

ROCE (avg)

21.64%

ROE (avg)

11.76%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.98

EV to EBIT

24.94

EV to EBITDA

18.55

EV to Capital Employed

6.06

EV to Sales

2.31

PEG Ratio

1.82

Dividend Yield

ROCE (Latest)

24.04%

ROE (Latest)

12.99%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

NET SALES(9M)

At Rs 557.17 cr has Grown at 21.21%

PBDIT(Q)

Highest at Rs 24.63 cr.

-1What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.72 times

Loading Valuation Snapshot...

Here's what is working for Windlas Biotech

Net Sales - Quarterly

Highest at Rs 195.02 cr and Grown

each quarter in the last five quarters

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Highest at Rs 24.63 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Here's what is not working for Windlas Biotech

Debtors Turnover Ratio- Half Yearly

Lowest at 3.72 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio